The prevalence of Th1/Th2 response, spleen changes and megakaryocytes were investigated in BALB/c mice (n = 138) infected with Leishmania infantum, and treated with Leishmania infantum 30Â (10 À30 ) biotherapy -BioLi30Â. We performed controlled experiments using 8-to-12-week-old mice, infected with 5 Â 10 7 L. infantum promastigotes, divided into eight groups: G1 (healthy), G2 (infected with L. infantum), G3 (BioLi30Â pre-treated), G4 (BioLi30Â pre/post-treated), G5 (BioLi30Â post-treated), G6 (Water 30Â post-treated), G7 (Antimonium crudum 30Â post-treated) and G8 (Glucantime Ò post-treated). G3 -G7
Megakaryocytes BALB/c Th1/Th2 response was measured after 49 days of infection, and cytokines (IFN-c, IL-4, IL-10, IL-12), as well as the Th1/Th2 correlation (IFN-c/IL-4 and IFN-c/IL-10), were analyzed. Spleen histological parameters were classified as: healthy appearance (G1); discreet (G3-G7), moderate (G2) and moderate to severe (G8) white pulp hyperplasia; proliferation of megakaryocytes (G2-G8), and intense disruption (G2-G8). All groups, except for G7, showed higher percentages of megakaryocytes per field ranging from 87% to 15%, when compared to healthy animals (G1). Th1 predominance in IFN-c/IL-4 ratio (comparing to G2) was detected in G4, G5, G6 and G7. Finally, pre/post (BioLi30x) and post-treatment (Antimonium crudum 30x) presented reduction of megakaryocytes/spleen changes due to immunomodulation animal process, controlling the infection process, probably by the Th1 cytokine predominance.
Ó 2017 Elsevier Ltd. All rights reserved.
Introduction
American visceral leishmaniasis (AVL) is a serious public health problem [1] . It is a worldwide neglected disease caused by Leishmania (L.) infantum, an intracellular parasite of the mononuclear phagocyte system cells, traditionally treated with Glucantime Ò [1] . Several studies have demonstrated immunomodulatory effects of homeopathic medicines on diseases caused by Leishmania sp. and other parasites [2] [3] [4] [5] . Considering these promising homeopathic results, we prepared Biotherapics, following the homeopathic pharmaceutical procedure [6] , and verified their efficacy. As control, we used Antimonium crudum 30Â, since this medication covers almost leishmaniasis symptoms totality and has been described in other works [5, 7] . Thus, the therapeutic and immunomodulatory biotherapy potential [2, 3, 7] motivated the present work in which the efficacy of a new biotherapy prepared with infective Leishmania infantum promastigotes (BioLi30Â) was evaluated in animal models. In the ALV disease, there is a predominance of Th2 CD4 + lymphocytes that will produce specific cytokines, increasing IL-4 and IL-10 due to the decrease of IL-12 and IFN-c (Th1-type cytokines), for a negative feedback mechanism [8] . Therefore, it is common to observe the predominance of Th2-type cytokines in infected animals and, in contrast, Th1 in treated animals, conferring infection resistance in the last one [8] . These changes in Th1/Th2 relation can be clearly observed in BALB/c mice, as they are an excellent model to evaluate the disease's immunomodulatory effects [8] . Spleens of BALB/c infected by L. infantum presented hypertrophy and hyperplasia of the mononuclear phagocyte system, accompanied by white pulp organ's lymphoid depletion [9] . In this organ, it is common to observe megakaryocytes, a platelet precursor cells [10] , whose numerical increase has been considerably shown in some works [9, 11] , indicating hematopoietic activity accompanied by a parasite expansion, taking to serious spleen functional disruptions [10, 11] . Thus, when tissue injury occurs, the organism tries to increase the production of platelets, since they will be responsible for maintaining the capillaries integrity [10] . In addition, platelets were recently recognized in the immune response activation, as elements involved in the elimination of pathogenic agents [4] . Therefore, the aim of this study is to evaluate the prevalence of Th1/Th2 response, histological spleen changes and megakaryocytes participation in immunomodulation process of BALB/c mice with AVL, treated with BioLi30Â.
Material and methods

Experimental design
Double blind controlled experiments using BALB/c mice (n = 138), with 8-to-12-week-old were performed. All animals were acquired at the Reference Center and Mice creation for Scientific Research of UFRJ after ethics committee approval (CEUA/UFRJ-066/14). Water and feed were provided ad libitum and the animals kept under controlled temperature and lighting conditions, with light/dark cycle (12 h/22 ± 1°C).
Test solutions and experimental groups
BioLi30x was prepared from a suspension containing 5x10 7 infective promastigotes of L. infantum/mL (strain MHOM/ BR/1974/PP75 -CLIOC/Fiocruz/RJ) at a ratio of 1:10, following the Brazilian Homeopathic Pharmacopoeia [6] . To prepare the dilutions, we used sterile phosphate buffer saline (PBS) from 1Â (10 À1 ) to 6Â (10 À6 ) potencies, since our preliminary experiments indicated parasite lyses when dynamization process was done with water as solvent up to 3Â. To ensure the protozoa integrity, PBS was used up to 6Â. After this, 7Â (10
À7
) to 30Â (10
À30
) potencies were prepared with sterile distilled water. For dynamizations, the diluted solutions were submitted to one hundred mechanical succussions in Homeopathic Brazilian Machine (Denise Ò -AUTIC). This procedure was performed because several works showed the biological effects of hydro-alcoholic dynamized solvents [2] [3] [4] [5] 7] . Besides, considering previous homeopathic uses of Antimonium crudum [5] , we also evaluated its effects (Antimonium crudum 30Â) in comparison to the traditional medicine Glucantime Ò (allopathic control). The Glucantime Ò (Sanofi-Aventis, lot 019106, 300 mg/mL) was prepared at 0.6 mg/100 mL of sterile phosphate buffer saline (PBS) [12] . BALB/c mice were randomly divided into eight groups (n = 16-18): G1 (healthy), G2 (infected with L. infantum), G3 (BioLi30Â pre-treated), G4 (BioLi30Â pre/post-treated), G5 (BioLi30Â posttreated), G6 (Water 30Â post-treated), G7 (Antimonium crudum 30Â post-treated) and G8 (Glucantime Ò post-treated).
Infection and treatment schemes
Except for G1, all groups were infected with L. infantum promastigotes. Parasites were previously maintained in PBHIL medium supplemented with 10% of fetal bovine serum (FBS) at 27°C [13] . At the end of log phase (120 h of growth), the cells were harvest, centrifuged (3500 rpm/5 min) and washed twice with PBS at pH 7.2. The mice were challenged with a suspension of 5 Â 10 7 promastigotes/100 mL in sterile PBS, intraperitoneally.
The animals were treated orally (G3-G7 groups) and intraperitoneally (G8). G3 and G4 were pre-treated for 21 days. At the end of this period, all groups were infected and, to ensure the disease establishment, there was a pause of 28 days prior the posttreatment beginning of G4-G8 for more 21 days [14] .
Euthanasia and collection of biological materials
After 49 days of infection, mice were anesthetized with chlorhydrates of ketamine (100-150 mg/kg) and xylazine (10-15 mg/kg), intramuscularly. Sequentially, 800 lL of blood were collected by cardiac puncture and the serum centrifuged at 10.000 rpm/10 min in centrifugal Eppendorf 5415-C, for cytokine analyzes. Euthanasia was performed by exposure to increasing CO 2 atmosphere. Spleen fragments were removed, fixed in blade with 4% paraformaldehyde, and stained with hematoxylin-eosin to perform histopathological changes. The slides were observed by two independent veterinarian pathologists to avoid interpretation bias. All experimental procedures involving animals were approved by Ethics Committee (CEUA) of UFRJ, under the protocol number 066/14.
Spleen changes and quantification of megakaryocytes
Histological spleen cuts were observed in optical microscope (Axyoplan 2, Zeiss/German). The spleen changes were sorted by score (0-5), indicating (in ascending order) the degree of white pulp hyperplasia with spleen disruption. The megakaryocytes were counted in six random fields. The average found in the groups were compared with the uninfected control (G1) and expressed in percentage.
Cytokines and ratio Th1/Th2
The cytokines IFN-c (pro-inflammatory which activates macrophages in order to inhibit infection and modulates B lymphocytes activities: Th1 response), IL-12 (induces T CD4 + cell differentiation, which is responsible for Th1 cytokines expansion), IL4 and IL-10 (anti-inflammatories with Th2 response: IL-4 suppresses macrophage functions dependent of IFN-c, and IL-10 inhibits the production of IL-12) were measured in serum (ng/mL) in three/four pools at the 49th day of infection. Samples were analyzed in duplicate in ELISA 96-well plates (Costar 3590 Corning), using the commercial kit R&D Systems (USA), and read in Elisa Bio-Rad plate reader at 450 nm. Sequentially, the ratio averages of Th1/Th2 (IFN-c/IL-4 and IFN-c/IL-10) were determined by dividing the values obtained in Th1 cytokine by Th2 cytokines.
Statistical analysis
One-way ANOVA was performed, followed by Tukey test to evaluate parametric variables (cytokines) and Kruskal-Wallis followed by Dunn test were performed to evaluate non-parametric variables (megakaryocytes). Graphpad Prism 5
Ò software was used. P values < 0.05 were considered statistically significant.
Results
Spleen changes and quantification of megakaryocytes
Spleen histological cuts presented: healthy appearance (G1); discreet (G3-G7), moderate (G2) and moderate to severe (G8; Fig. 1A ) white pulp hyperplasia; proliferation of and megakaryocytes (G2-G8); and intense disruption (G2-G8; Fig. 1B and C) . calculated dividing the groups' averages by G1 average (healthy animals). Statistical differences were revealed by non-parametric Kruskal-Wallis/Dunn, indicating that only G7 animals showed 10% of percentage reduction (p > 0.05) when compared to G1. All other groups showed higher values than those recorded in G1: G2 (87%; p < 0.001), G8 (53%; p < 0.001), G6 (39%; p < 0.001), G3 (29%; p < 0.05), G5 (23%; p > 0.05) and G4 (15%; p > 0.05). Compared to G2 (L. infantum), a statistically significant difference was found between this group and G3, G4, G5 and G7 (p < 0.001). Among treated groups, the following p-values were found: G7 with G3, G4, G5, G6 and G8 (p < 0.001); G4 with G6 and G8 (p < 0.01), and G5 with G6 and G8 (p < 0.05). (E) Correlation Megakaryocytes/Spleen changes: the line graph indicates the mean quantity of megakaryocytes/field, where continuous straight line represents the value found in G1 (healthy). The ordinate on the left indicates the numerical amount of megakaryocytes. The bar graph in green color indicates the variations of commitments of spleen changes found in the groups studied. The ordinate on the right indicates the score of histological changes observed in the spleen cuts, where the number 0 indicates no change, and the number 5 indicates maximum change. The groups are represented as follows: G1 (healthy), G2 (infected with L. infantum), G3 (BioLi30x pre-treated), G4 (BioLi30Â pre/post-treated), G5 (BioLi30Â post-treated), G6 (Water 30Â post-treated), G7 (Antimonium crudum 30Â post-treated) and G8 (Glucantime Ò post-treated).
The percentage of megakaryocytes and their relationship with spleen changes are shown in Fig. 1D and E, respectively.
Cytokines and Th1/Th2 ratio
A decrease in IFN-c and IL-12 concentrations in G2 (L. infantum) was observed when compared to G1 (healthy). Moreover, an increase occurred with IL4 and IL-10 concentrations, as expected in the L. infantum infection. Comparing G1 with treated groups, there was no significant difference in IFN-c cytokine (p > 0.05), but there was for IL-4 in G8, IL-10 in G6, and IL-12 in G5 (p < 0.05). Regarding the comparison among G2 and treated groups, there was a significant difference (p < 0.05) with G5 in IFN-c, G8 in IL-4, as well as G5 and G6 in IL-12. IL-10 production had no significant difference between G2 and treated groups (p > 0.05). However, it was observed a decreasing of this cytokine in G4. The IFN-c/IL4 ratio analysis revealed a significant difference in G1 with G6 and G8 (p < 0.05), as well as between G2 and G6 (p < 0.05). No statistical differences were observed in the IFN-c/ IL-10 ratio (p > 0.05) between all analyzed groups (Fig. 2) .
Discussion
It is known that megakaryocytes are related to L. infantum infection resistance and they increase in an attempt to control the disease [5, 9, 11] . The parasite can induce replication of these cells in the spleen and, due to their immaturity, the infection will be enhanced [9, 11] . This information corroborates Fig. 1D and E data, due to the higher number of cells observed in all infected groups, except in G7, where megakaryocytes diminishing could be correlated to anti-inflammatory response, and to the inhibition of mononuclear cell migration to the injury site, as previously described [5] . These effects in animals with leishmaniasis probably occur in parallel to the inhibition of megakaryocytes expansion in spleen. Fig. 2 showed Th1 predominance in G1 (uninfected control) when compared to G2 (infected but untreated control), by IFN-c increase concomitant with IL-4 and IL-10 decreasing. BALB/c mice are susceptible to L. infantum [15] . Therefore, Th2 response observed in G2 confirms this fact, since it was related to a worst prognosis [5] . Maybe G2 megakaryocytes increase could be an immune system attempt to create L. infantum infection resistance [9, 11] .
Regarding the analyzed cytokines in this study (Fig. 2) , the increase of IFN-c concentration in G5 (BioLi30Â post-treated) may be related to the polyclonal activation of B-cells, leading to antibody production and raising levels of IgM and IgG [8] . However, it was observed, within this dynamic, that both G4 (BioLi30Â pre/post-treated) and G7 (Antimonium crudum 30Â post-treated) were able to increase this cytokine, in order to return to G1 (healthy animals) basal levels. By positive feedback mechanism, the results on IL-12 were similar to IFN-c. In IL-4, the raising of this cytokine concentration in G8 (Glucantime Ò post-treated) may be related to a cytotoxic effect caused by Glucantime Ò [1] , since the tissue damage will activate T lymphocytes and will increase the IgE production [10] . In IL-10, the raising levels observed in G6 (Water 30Â post-treated) may be related to the negative feedback mechanism occurred between this cytokine and IL-12/IFN-c. Additionally, IFN-c has also increased in this same group. These findings indicated water effects were unspecific, probably due to the process of homeopathic dynamization that may form aggregates known as ''nanobubbles" or ''clusters", which make immunomodulatory reactions. The IL-10 diminishing in G4 may probably indicate that smaller macrophage activation occurred with the pre/ post-treatment (promoted by BioLi30X), which induced a better immune defense to the animals of this group. Whereas, we cannot say which group caused greater or less resistance to the host, Among treated groups (G3-G8) these differences were represented by '' * " with the same corresponding letter, such as: (A) IFN-c: G5 presented IFN-c increased production when compared to G3, G4 and G7 (p < 0.01), and G8 (p < 0.05). (B) IL-4: G8 presented IL-4 increased production when compared to G3 (p < 0.05), G4, G5, G6 and G7 (p < 0.001). It was also observed difference between G3 and G6 (p < 0.01). (C) IL-10: G4 presented IL-10 decreased production, when compared to G3 (p < 0.05), G6 (p < 0.001) and G7 (p < 0.01). (D) IL-12: G5 presented IL-12 increased production when compared to G3, G4 and G7 (p < 0.001), and G8 (p < 0.01). It was also observed a significant difference between G6 with G3, and with G7 (p < 0.05). (E) Ratio IFN-c/IL-4: it was observed Th1 predominance in G4, G5, G6 and G7, and Th2 in G3 and G8. The group G6 showed increase when compared with G2, G3, G4, G5, G7 and G8 (p < 0.001); and G5 showed increase when compared with G3 and G8 (p < 0.05). (F) Correlation IFN-c/IL-10: it was observed Th1 predominance in G4, G5, G7 and G8, and Th2 in groups G3 and G6, with no significant difference among all analyzed groups (p > 0.05). Statistical differences were revealed by parametric One way ANOVA -Tukey test.
exclusively by the individual dosages of cytokines, making necessary the analysis of Th1/Th2 ratio, as below described.
In G3 (BioLi30Â pre-treated), probably the oral immunization promoted by prior treatment could have led to a humoral immune response against the parasite antigens, enhancing Th2 cytokines. In G6 (Water 30Â post-treated), although Th1 cytokine predominance has occurred, only by increased IFN-c in the ratio IFN-c/IL-4, the treatment in question was not able to control megakaryocytes elevation and presented the highest level of spleen changes (Fig. 1) , staying just below G2 (infected with L. infantum) and G8 (Glucantime Ò post-treated). In G8, this Th2 predominance, as well as spleen changes and elevation of megakaryocytes, probably occurred due to the cytotoxicity of Glucantime Ò . Regarding G4 (BioLi30Â pre/post-treated), G5 (BioLi30Â post-treated) and G7 (Antimonium crudum 30Â post-treated), changes in Th1/Th2 ratio were observed, verifying predominance of Th1 cytokine. However, comparing G4 with G5, the second one caused higher megakaryocytes production and spleen changes. The comparison between G4 and G7 showed that both groups had equal levels of white pulp hyperplasia with spleen disruption, and expressed the lowest megakaryocytes concentration, indicating systemic inflammation reduction. In conclusion, BioLi30Â pre/post-treatment and Antimonium crudum 30Â post-treatment were better able to contain the disease, suggesting they can modulate the immune system toward as better prognosis (Th1 response), as described in other works with homeopathic medicines [4, 5, 7] . However, the clinical significance of these findings needs to be further investigated.
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